Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Ezhilarasi Chendamarai
Observed names:
Chendamarai, E.,
E Chendamarai,
E. Chendamarai,
Ezhil Chendamarai
Institution:
Christian Medical College, Vellore
Observed institutions:
Christian Medical College, Vellore,
Washington University in St. Louis,
Rabin Medical Center,
Centre Hospitalier Universitaire de Montpellier,
Christian Medical College,
Montefiore Einstein Comprehensive Cancer Center,
The Ohio State University
show all 7
ORCID:
0000-0001-7032-9301
Observed ORCID:
0000-0001-7032-9301
OpenAlex ID:
A5058755695
Immune Escape of Relapsed AML Cells after Allogeneic Transplantation
2018
·
Matthew J. Christopher
, Allegra A. Petti
, et al.
·
New England Journal of Medicine
·
511
PDF
Single-Agent Arsenic Trioxide in the Treatment of Newly Diagnosed Acute Promyelocytic Leukemia: Long-Term Follow-Up Data
2010
·
Vikram Mathews
, Biju George
, et al.
·
Journal of Clinical Oncology
·
275
Comprehensive mutational analysis of primary and relapse acute promyelocytic leukemia
2016
·
V Madan
, P Shyamsunder
, et al.
·
Leukemia
·
143
PDF
Comparison of Clinical Outcomes of Patients with Relapsed Acute Promyelocytic Leukemia Induced with Arsenic Trioxide and Consolidated with Either an Autologous Stem Cell Transplant or an Arsenic Trioxide–Based Regimen
2009
·
Rajasekar Thirugnanam
, Biju George
, et al.
·
Transplantation and Cellular Therapy
·
97
PDF
Continuous blockade of CXCR4 results in dramatic mobilization and expansion of hematopoietic stem and progenitor cells
2017
·
Darja Karpova
, Julie K. Ritchey
, et al.
·
Blood
·
63
Role of minimal residual disease monitoring in acute promyelocytic leukemia treated with arsenic trioxide in frontline therapy
2012
·
Ezhilarasi Chendamarai
, Poonkuzhali Balasubramanian
, et al.
·
Blood
·
63
Treatment of Acute Promyelocytic Leukemia With Single-agent Arsenic Trioxide
2011
·
Vikram Mathews
, Ezhilarasi Chendamarai
, et al.
·
Mediterranean Journal of Hematology and Infectious Diseases
·
53
PDF
Comparison of Newly Diagnosed and Relapsed Patients with Acute Promyelocytic Leukemia Treated with Arsenic Trioxide: Insight into Mechanisms of Resistance
2015
·
Ezhilarasi Chendamarai
, Saravanan Ganesan
, et al.
·
PLoS ONE
·
51
PDF
Targeting VLA4 integrin and CXCR2 mobilizes serially repopulating hematopoietic stem cells
2019
·
Darja Karpova
, Michael P. Rettig
, et al.
·
Journal of Clinical Investigation
·
45
PDF
Apolipoprotein M Attenuates Anthracycline Cardiotoxicity and Lysosomal Injury
2023
·
Zhen Guo
, Carla Valenzuela Ripoll
, et al.
·
JACC Basic to Translational Science
·
41
Flotetuzumab and other T-cell immunotherapies upregulate MHC class II expression on acute myeloid leukemia cells
2022
·
Joseph C. Rimando
, Ezhilarasi Chendamarai
, et al.
·
Blood
·
36
PDF
Rationale and efficacy of proteasome inhibitor combined with arsenic trioxide in the treatment of acute promyelocytic leukemia
2016
·
S Ganesan
, A A Alex
, et al.
·
Leukemia
·
35
PDF
Erratum: Comprehensive mutational analysis of primary and relapse acute promyelocytic leukemia
2016
·
V Madan
, P Shyamsunder
, et al.
·
Leukemia
·
34
PDF
Selinexor combined with cladribine, cytarabine, and filgrastim in relapsed or refractory acute myeloid leukemia
2019
·
Ramzi Abboud
, Ezhilarasi Chendamarai
, et al.
·
Haematologica
·
29
PDF
Spectrum ofBCR-ABLkinase domain mutations in patients with chronic myeloid leukemia from India with suspected resistance to imatinib-mutations are rare and have different distributions
2009
·
Preetha Markose
, Ezhilarasi Chendamarai
, et al.
·
Leukemia & lymphoma/Leukemia and lymphoma
·
28
Metabolic adaptation drives arsenic trioxide resistance in acute promyelocytic leukemia
2021
·
Nithya Balasundaram
, Saravanan Ganesan
, et al.
·
Blood Advances
·
21
PDF
Targeting CXCR4, VLA-4, and CXCR2 for hematopoietic stem cell mobilization
2024
·
Daniel Cancilla
, Michael P. Rettig
, et al.
·
Blood Advances
·
16
PDF
Ixazomib, an oral proteasome inhibitor, induces rapid mobilization of hematopoietic progenitor cells in mice
2018
·
Armin Ghobadi
, Michael P. Rettig
, et al.
·
Blood
·
13
International Reporting Scale of BCR-ABL1 Fusion Transcript in Chronic Myeloid Leukemia: First Report from India
2012
·
Poonkuzhali Balasubramanian
, Ezhilarasi Chendamarai
, et al.
·
Acta Haematologica
·
9
Streptavidin-drug conjugates streamline optimization of antibody-based hematopoietic stem cell transplant conditioning
2025
·
Aditya R. Yelamali
, Ezhilarasi Chendamarai
, et al.
·
Blood Immunology & Cellular Therapy
·
8
ABCB6 RNA expression in leukemias—expression is low in acute promyelocytic leukemia and FLT3-ITD-positive acute myeloid leukemia
2013
·
Ajay Abraham
, Sreeja Karathedath
, et al.
·
Annals of Hematology
·
8
Arsenic Trioxide Resistance: More to It Than Mutations in PML-RARα
2014
·
Ansu Abu Alex
, Ezhilarasi Chendamarai
, et al.
·
Blood
·
7
Venetoclax induces mitochondrial apoptosis and autophagy to overcome arsenic trioxide resistance in acute promyelocytic leukemia
2026
·
Deepshikha Dutta
, Akash Maity
, et al.
·
Journal of Translational Medicine
·
6
Single Agent Arsenic Trioxide in the Treatment of Newly Diagnosed Acute Promyelocytic Leukemia: Long Term Follow-up Data.
2009
·
Vikram Mathews
, Biju George
, et al.
·
Blood
·
4
Single Agent Arsenic Trioxide Regimen for the Treatment of Newly Diagnosed Acute Promyelocytic Leukemia: Initial Results of a Multicenter Randomized Controlled Study From India to Study the Optimal Duration of Arsenic Trioxide Maintenance Therapy (IAPLSG04).
2009
·
Vikram Mathews
, Biju George
, et al.
·
Blood
·
4
Show more works
View as search
Works count:
51
Citation count:
1,612
H-index:
16
I10-index:
18
Year
Topic
Type